APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tumor Gene Test Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tumor Gene Test Service Market Outlook and Growth Opportunities 2026

2 January 2026190 pages

Choose your research edition.

Industry ResearchTumor Gene Test Service Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Gene Test Service Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Tumor Gene Test Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Gene Test Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Tumor Gene Test Service Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Tumor Gene Test Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tumor Gene Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tumor Gene Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor Gene Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tumor Gene Test Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tumor Gene Test Service market include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, 10x Genomics, QIAGEN, GEEWIZ and MACROGEN, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Tumor Gene Test Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tumor Gene Test Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tumor Gene Test Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Tumor Gene Test Service market.

Tumor Gene Test Service Segment by Company

Illumina

BGI Genomics Co.,Ltd.

Agilent Technologies

Macrogen

Pacific Biosciences

10x Genomics

QIAGEN

GEEWIZ

MACROGEN

Oxford Nanopore Technologies

Tumor Gene Test Service Segment by Type

Tumor Tissue

Blood

Tumor Gene Test Service Segment by Application

Medical Institution

Scientific Research Institutions

Pharmaceutical Companies

Individual User

Tumor Gene Test Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Tumor Gene Test Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Tumor Gene Test Service key companies, revenue, market share, and recent developments.

3. To split the Tumor Gene Test Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Tumor Gene Test Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tumor Gene Test Service significant trends, drivers, influence factors in global and regions.

6. To analyze Tumor Gene Test Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Gene Test Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Gene Test Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Gene Test Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tumor Gene Test Service industry.

Chapter 3: Detailed analysis of Tumor Gene Test Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Tumor Gene Test Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Tumor Gene Test Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tumor Gene Test Service Industry Trends Table 2. Tumor Gene Test Service Industry Drivers Table 3. Tumor Gene Test Service Industry Opportunities and Challenges Table 4. Tumor Gene Test Service Industry Restraints Table 5. Global Tumor Gene Test Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tumor Gene Test Service Revenue Share by Company (2021-2026) Table 7. Global Tumor Gene Test Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Tumor Gene Test Service Key Company Manufacturing Base & Headquarters Table 9. Global Tumor Gene Test Service Company, Product Type & Application Table 10. Global Tumor Gene Test Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Tumor Gene Test Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Tumor Tissue Table 15. Significant Companies of Blood Table 16. Global Tumor Gene Test Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Tumor Gene Test Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Tumor Gene Test Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Tumor Gene Test Service Sales Value Share by Type (2021-2026) Table 20. Global Tumor Gene Test Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Institution Table 22. Significant Companies of Scientific Research Institutions Table 23. Significant Companies of Pharmaceutical Companies Table 24. Significant Companies of Individual User Table 25. Global Tumor Gene Test Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Tumor Gene Test Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Tumor Gene Test Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Tumor Gene Test Service Sales Value Share by Application (2021-2026) Table 29. Global Tumor Gene Test Service Sales Value Share by Application (2027-2032) Table 30. Global Tumor Gene Test Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Tumor Gene Test Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Tumor Gene Test Service Sales Value Share by Region (2021-2026) Table 33. Global Tumor Gene Test Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Tumor Gene Test Service Sales Value Share by Region (2027-2032) Table 35. Global Tumor Gene Test Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Tumor Gene Test Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Tumor Gene Test Service Sales Value Market Share by Country (2021-2026) Table 38. Global Tumor Gene Test Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Tumor Gene Test Service Sales Value Market Share by Country (2027-2032) Table 40. Illumina Company Information Table 41. Illumina Business Overview Table 42. Illumina Tumor Gene Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Illumina Tumor Gene Test Service Product Portfolio Table 44. Illumina Recent Development Table 45. BGI Genomics Co.,Ltd. Company Information Table 46. BGI Genomics Co.,Ltd. Business Overview Table 47. BGI Genomics Co.,Ltd. Tumor Gene Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. BGI Genomics Co.,Ltd. Tumor Gene Test Service Product Portfolio Table 49. BGI Genomics Co.,Ltd. Recent Development Table 50. Agilent Technologies Company Information Table 51. Agilent Technologies Business Overview Table 52. Agilent Technologies Tumor Gene Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Agilent Technologies Tumor Gene Test Service Product Portfolio Table 54. Agilent Technologies Recent Development Table 55. Macrogen Company Information Table 56. Macrogen Business Overview Table 57. Macrogen Tumor Gene Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Macrogen Tumor Gene Test Service Product Portfolio Table 59. Macrogen Recent Development Table 60. Pacific Biosciences Company Information Table 61. Pacific Biosciences Business Overview Table 62. Pacific Biosciences Tumor Gene Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Pacific Biosciences Tumor Gene Test Service Product Portfolio Table 64. Pacific Biosciences Recent Development Table 65. 10x Genomics Company Information Table 66. 10x Genomics Business Overview Table 67. 10x Genomics Tumor Gene Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. 10x Genomics Tumor Gene Test Service Product Portfolio Table 69. 10x Genomics Recent Development Table 70. QIAGEN Company Information Table 71. QIAGEN Business Overview Table 72. QIAGEN Tumor Gene Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. QIAGEN Tumor Gene Test Service Product Portfolio Table 74. QIAGEN Recent Development Table 75. GEEWIZ Company Information Table 76. GEEWIZ Business Overview Table 77. GEEWIZ Tumor Gene Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. GEEWIZ Tumor Gene Test Service Product Portfolio Table 79. GEEWIZ Recent Development Table 80. MACROGEN Company Information Table 81. MACROGEN Business Overview Table 82. MACROGEN Tumor Gene Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. MACROGEN Tumor Gene Test Service Product Portfolio Table 84. MACROGEN Recent Development Table 85. Oxford Nanopore Technologies Company Information Table 86. Oxford Nanopore Technologies Business Overview Table 87. Oxford Nanopore Technologies Tumor Gene Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Oxford Nanopore Technologies Tumor Gene Test Service Product Portfolio Table 89. Oxford Nanopore Technologies Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Tumor Gene Test Service Product Image Figure 2. Global Tumor Gene Test Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Tumor Gene Test Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Tumor Tissue Image Figure 8. Blood Image Figure 9. Global Tumor Gene Test Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Tumor Gene Test Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Tumor Gene Test Service Sales Value Share by Type (2021-2032) Figure 12. Medical Institution Image Figure 13. Scientific Research Institutions Image Figure 14. Pharmaceutical Companies Image Figure 15. Individual User Image Figure 16. Global Tumor Gene Test Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Tumor Gene Test Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Tumor Gene Test Service Sales Value Share by Application (2021-2032) Figure 19. Global Tumor Gene Test Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Tumor Gene Test Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Tumor Gene Test Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Tumor Gene Test Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Tumor Gene Test Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Tumor Gene Test Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Tumor Gene Test Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Tumor Gene Test Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Tumor Gene Test Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Tumor Gene Test Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Tumor Gene Test Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Tumor Gene Test Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Tumor Gene Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Tumor Tissue
  • Blood
Applications
  • Medical Institution
  • Scientific Research Institutions
  • Pharmaceutical Companies
  • Individual User
Companies covered
  • Illumina
  • BGI Genomics Co.,Ltd.
  • Agilent Technologies
  • Macrogen
  • Pacific Biosciences
  • 10x Genomics
  • QIAGEN
  • GEEWIZ
  • MACROGEN
  • Oxford Nanopore Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tumor Gene Test Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tumor Gene Test Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Tumor Gene Test Service Market Dynamics
  1. 2.1 Tumor Gene Test Service Industry Trends
  2. 2.2 Tumor Gene Test Service Industry Drivers
  3. 2.3 Tumor Gene Test Service Industry Opportunities and Challenges
  4. 2.4 Tumor Gene Test Service Industry Restraints
3 Tumor Gene Test Service Market by Company
  1. 3.1 Global Tumor Gene Test Service Company Revenue Ranking in 2025
  2. 3.2 Global Tumor Gene Test Service Revenue by Company (2021-2026)
  3. 3.3 Global Tumor Gene Test Service Company Ranking (2024-2026)
  4. 3.4 Global Tumor Gene Test Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Tumor Gene Test Service Company Product Type and Application
  6. 3.6 Global Tumor Gene Test Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Tumor Gene Test Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Tumor Gene Test Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Tumor Gene Test Service Market by Type
  1. 4.1 Tumor Gene Test Service Type Introduction
  2. 4.1.1 Tumor Tissue
  3. 4.1.2 Blood
  4. 4.2 Global Tumor Gene Test Service Sales Value by Type
  5. 4.2.1 Global Tumor Gene Test Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tumor Gene Test Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Tumor Gene Test Service Sales Value Share by Type (2021-2032)
5 Tumor Gene Test Service Market by Application
  1. 5.1 Tumor Gene Test Service Application Introduction
  2. 5.1.1 Medical Institution
  3. 5.1.2 Scientific Research Institutions
  4. 5.1.3 Pharmaceutical Companies
  5. 5.1.4 Individual User
  6. 5.2 Global Tumor Gene Test Service Sales Value by Application
  7. 5.2.1 Global Tumor Gene Test Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Tumor Gene Test Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Tumor Gene Test Service Sales Value Share by Application (2021-2032)
6 Tumor Gene Test Service Regional Value Analysis
  1. 6.1 Global Tumor Gene Test Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tumor Gene Test Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Tumor Gene Test Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Tumor Gene Test Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tumor Gene Test Service Sales Value (2021-2032)
  7. 6.3.2 North America Tumor Gene Test Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Tumor Gene Test Service Sales Value (2021-2032)
  10. 6.4.2 Europe Tumor Gene Test Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Tumor Gene Test Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Tumor Gene Test Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Tumor Gene Test Service Sales Value (2021-2032)
  16. 6.6.2 South America Tumor Gene Test Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Tumor Gene Test Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Tumor Gene Test Service Sales Value Share by Country, 2025 VS 2032
7 Tumor Gene Test Service Country-level Value Analysis
  1. 7.1 Global Tumor Gene Test Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tumor Gene Test Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Tumor Gene Test Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Tumor Gene Test Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Tumor Gene Test Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Tumor Gene Test Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Tumor Gene Test Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Illumina
  2. 8.1.1 Illumina Company Information
  3. 8.1.2 Illumina Business Overview
  4. 8.1.3 Illumina Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Illumina Tumor Gene Test Service Product Portfolio
  6. 8.1.5 Illumina Recent Developments
  7. 8.2 BGI Genomics Co.,Ltd.
  8. 8.2.1 BGI Genomics Co.,Ltd. Company Information
  9. 8.2.2 BGI Genomics Co.,Ltd. Business Overview
  10. 8.2.3 BGI Genomics Co.,Ltd. Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BGI Genomics Co.,Ltd. Tumor Gene Test Service Product Portfolio
  12. 8.2.5 BGI Genomics Co.,Ltd. Recent Developments
  13. 8.3 Agilent Technologies
  14. 8.3.1 Agilent Technologies Company Information
  15. 8.3.2 Agilent Technologies Business Overview
  16. 8.3.3 Agilent Technologies Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Agilent Technologies Tumor Gene Test Service Product Portfolio
  18. 8.3.5 Agilent Technologies Recent Developments
  19. 8.4 Macrogen
  20. 8.4.1 Macrogen Company Information
  21. 8.4.2 Macrogen Business Overview
  22. 8.4.3 Macrogen Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Macrogen Tumor Gene Test Service Product Portfolio
  24. 8.4.5 Macrogen Recent Developments
  25. 8.5 Pacific Biosciences
  26. 8.5.1 Pacific Biosciences Company Information
  27. 8.5.2 Pacific Biosciences Business Overview
  28. 8.5.3 Pacific Biosciences Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pacific Biosciences Tumor Gene Test Service Product Portfolio
  30. 8.5.5 Pacific Biosciences Recent Developments
  31. 8.6 10x Genomics
  32. 8.6.1 10x Genomics Company Information
  33. 8.6.2 10x Genomics Business Overview
  34. 8.6.3 10x Genomics Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 10x Genomics Tumor Gene Test Service Product Portfolio
  36. 8.6.5 10x Genomics Recent Developments
  37. 8.7 QIAGEN
  38. 8.7.1 QIAGEN Company Information
  39. 8.7.2 QIAGEN Business Overview
  40. 8.7.3 QIAGEN Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 QIAGEN Tumor Gene Test Service Product Portfolio
  42. 8.7.5 QIAGEN Recent Developments
  43. 8.8 GEEWIZ
  44. 8.8.1 GEEWIZ Company Information
  45. 8.8.2 GEEWIZ Business Overview
  46. 8.8.3 GEEWIZ Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GEEWIZ Tumor Gene Test Service Product Portfolio
  48. 8.8.5 GEEWIZ Recent Developments
  49. 8.9 MACROGEN
  50. 8.9.1 MACROGEN Company Information
  51. 8.9.2 MACROGEN Business Overview
  52. 8.9.3 MACROGEN Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MACROGEN Tumor Gene Test Service Product Portfolio
  54. 8.9.5 MACROGEN Recent Developments
  55. 8.10 Oxford Nanopore Technologies
  56. 8.10.1 Oxford Nanopore Technologies Company Information
  57. 8.10.2 Oxford Nanopore Technologies Business Overview
  58. 8.10.3 Oxford Nanopore Technologies Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Oxford Nanopore Technologies Tumor Gene Test Service Product Portfolio
  60. 8.10.5 Oxford Nanopore Technologies Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst